Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis

2.1    Overview
2.2    Legal Requirements and Framework in the U.S.
         2.2.1    FDA Regulation
2.4    Legal Requirements and Framework in Asia-Pacific
         2.4.1    China
         2.4.2    Japan

3.1    Overview
3.2    Impact Analysis
3.3    Market Drivers
3.4    Market Restraints
3.5    Market Opportunities

4.1    Overview
4.2    Product Launch and Upgradations
4.3    Product Approvals and Business Funding
4.4    Synergistic Activities
4.5    Mergers and Acquisitions
4.6    Market Share Analysis (by Company), 2023 and 2024
4.7    Growth Share Analysis (by Company)

5.1    Overview
5.2    Cell-Free DNA Isolation and Extraction Kits
5.3    Cell-Free DNA Isolation and Extraction Tubes
5.4    Other Consumables

6.1    Overview
6.2    Next-Generation Sequencing (NGS)
6.3    Polymerase Chain Reaction (PCR)
6.4    Real-Time Polymerase Chain Reaction (RT-PCR)
6.5    Digital Polymerase Chain Reaction (dPCR)
6.6    Other Platforms

7.1    Overview
7.2    Magnetic Beads-Based
7.3    Spin Column-Based
7.4    Other Techniques

8.1    Overview
8.2    Non-Invasive Prenatal Testing (NIPT)
8.3    Oncology
         8.3.1    Solid Tumor
         8.3.2    Hematological Malignancies
8.4    Transplant Rejection
8.5    Other Applications

9.1    Overview
9.2    Pharmaceutical and Biotechnology Companies
9.3    Academic Research Institutes and Laboratories
9.4    Contract Research Organizations (CROs)
9.5    Clinical Diagnostic Centers
9.6    Other End Users

10.1    Overview
10.2    North America
           10.2.1    U.S.
           10.2.2    Canada
10.3    Europe
           10.3.1    Germany
           10.3.2    France
           10.3.3    U.K.
           10.3.4    Italy
           10.3.5    Spain
           10.3.6    Denmark
           10.3.7    Rest-of-Europe
10.4    Asia-Pacific
           10.4.1    China
           10.4.2    India
           10.4.3    Japan
           10.4.4    South Korea
           10.4.5    Australia
           10.4.6    Singapore
           10.4.7    Rest-of-Asia-Pacific (RoAPAC)
10.5    Latin America
10.6    Brazil
           10.6.1    Mexico
           10.6.2    Rest-of-Latin America (RoLA)
           10.6.3    Rest-of-the-World

11.1    Thermo Fisher Scientific Inc.
           11.1.1    Company Overview
           11.1.2    Product Portfolio
           11.1.3    Target Customers/End Users
           11.1.4    Analyst View
11.2    QIAGEN
           11.2.1    Company Overview
           11.2.2    Product Portfolio
           11.2.3    Target Customers/End Users
           11.2.4    Analyst View
11.3    Danaher Corporation
           11.3.1    Company Overview
           11.3.2    Product Portfolio
           11.3.3    Target Customers/End Users
           11.3.4    Analyst View
11.4    PerkinElmer, Inc.
           11.4.1    Company Overview
           11.4.2    Product Portfolio
           11.4.3    Target Customers/End Users
           11.4.4    Analyst View
11.5    Endress+Hauser AG
           11.5.1    Company Overview
           11.5.2    Product Portfolio
           11.5.3    Target Customers/End Users
           11.5.4    Analyst View
11.6    Agilent Technologies, Inc.
           11.6.1    Company Overview
           11.6.2    Product Portfolio
           11.6.3    Target Customers/End Users
           11.6.4    Analyst View
11.7    F. Hoffmann-La Roche Ltd.
           11.7.1    Company Overview
           11.7.2    Product Portfolio
           11.7.3    Target Customers/End Users
           11.7.4    Analyst View
11.8    Merck KGaA
           11.8.1    Company Overview
           11.8.2    Product Portfolio
           11.8.3    Target Customers/End Users
           11.8.4    Analyst View
11.9    llumina, Inc.
           11.9.1    Company Overview
           11.9.2    Product Portfolio
           11.9.3    Target Customers/End Users
           11.9.4    Analyst View
11.10    Takara Bio Inc.
           11.10.1    Company Overview
           11.10.2    Product Portfolio
           11.10.3    Target Customers/End Users
           11.10.4    Analyst View
           11.11    Aline Biosciences
           11.11.1    Company Overview
           11.11.2    Product Portfolio
           11.11.3    Target Customers/End Users
           11.11.4    Analyst View
11.12    EpiGentek Group, Inc.
           11.12.1    Company Overview
           11.12.2    Product Portfolio
           11.12.3    Target Customers/End Users
           11.12.4    Analyst View
11.13    Omega Bio-tek, Inc.
           11.13.1    Company Overview
           11.13.2    Product Portfolio
           11.13.3    Target Customers/End Users
           11.13.4    Analyst View
11.14    Promega Corporation
           11.14.1    Company Overview
           11.14.2    Product Portfolio
           11.14.3    Target Customers/End Users
           11.14.4    Analyst View
11.15    Streck, Inc.
           11.15.1    Company Overview
           11.15.2    Product Portfolio
           11.15.3    Target Customers/End Users
           11.15.4    Analyst View
11.16    AccuBioMed Co., Ltd.
           11.16.1    Company Overview
           11.16.2    Product Portfolio
           11.16.3    Target Customers/End Users
           11.16.4    Analyst View
11.17    AMSBIO
           11.17.1    Company Overview
           11.17.2    Product Portfolio
           11.17.3    Target Customers/End Users
           11.17.4    Analyst View
11.18    Covaris, Inc.
           11.18.1    Company Overview
           11.18.2    Product Portfolio
           11.18.3    Target Customers/End Users
           11.18.4    Analyst View
11.19    EntroGen, Inc.
           11.19.1    Company Overview
           11.19.2    Product Portfolio
           11.19.3    Target Customers/End Users
           11.19.4    Analyst View
11.20    NeoGeneStar LLC
           11.20.1    Company Overview
           11.20.2    Product Portfolio
           11.20.3    Target Customers/End Users
           11.20.4    Analyst View
11.21    Norgen Biotek Corporation
           11.21.1    Company Overview
           11.21.2    Product Portfolio
           11.21.3    Target Customers/End Users
           11.21.4    Analyst View
11.22    STRATEC SE
           11.22.1    Company Overview
           11.22.2    Product Portfolio
           11.22.3    Target Customers/End Users
           11.22.4    Analyst View
11.23    System Biosciences, LLC
           11.23.1    Company Overview
           11.23.2    Product Portfolio
           11.23.3    Target Customers/End Users
           11.23.4    Analyst View

Table:    Global Cell-Free DNA Isolation and Extraction Market Dynamics, Impact Analysis
Table:    Global Cell-Free DNA Isolation and Extraction Market (by Product), $Million, 2023-2035
Table:    Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2023-2035
Table:    Global Cell-Free DNA Isolation and Extraction Market (by Techniques), $Million, 2023-2035
Table:     Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2023-2035
Table:    Global Cell-Free DNA Isolation and Extraction Market (End User), $Million, 2023-2035
Table:    Global Cell-Free DNA Isolation and Extraction Market (Region), $Million, 2023-2035

Figure:    Global Cell-Free DNA Isolation and Extraction Market, Dynamics Impact Analysis
Figure:    Global Cell-Free DNA Isolation and Extraction Market Coverage
Figure:    Global Cell-Free DNA Isolation and Extraction Market, Patent Analysis, January 2022-March 2025
Figure:    Global Cell-Free DNA Isolation and Extraction Market, Competitive Landscape, January 2022-March 2025